Literature DB >> 8078918

Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors.

J Liu1, J Nickolenko, F R Sharp.   

Abstract

Morphine induced the c-fos and junB immediate early genes in neurons of the medial and ventral striatum and nucleus accumbens. Induction of c-fos and junB mRNA and Fos protein was blocked by naloxone, the D1 dopamine (DA) receptor antagonists SCH23390 and SCH39166, and the N-methyl-D-aspartate (NMDA) glutamate receptor antagonist MK801. SCH23390 attenuated morphine induction of AP-1 binding in striatum, suggesting that c-fos and junB contribute to AP-1 binding. SCH23390 and MK801 did not block morphine induction of c-fos and junB in septum. Since the morphine induction of c-fos and junB in striatum and nucleus accumbens (NA) was similar to that observed with cocaine and amphetamine, these data support current concepts that limbic striatum and NA are among the brain regions that mediate drug abuse. Furthermore, since DA and NMDA receptors may mediate opiate reward and opiate induction of c-fos and junB, the DA/NMDA regulation of c-fos and junB and their target genes may produce long-term changes in the striatal and NA circuits that contribute to opiate drug abuse.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8078918      PMCID: PMC44641          DOI: 10.1073/pnas.91.18.8537

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  79 in total

Review 1.  Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun.

Authors:  J I Morgan; T Curran
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

2.  Anatomically distinct opiate receptor fields mediate reward and physical dependence.

Authors:  M A Bozarth; R A Wise
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

3.  Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos.

Authors:  G S Robertson; S R Vincent; H C Fibiger
Journal:  Brain Res       Date:  1990-07-23       Impact factor: 3.252

4.  Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum.

Authors:  J J Bouyer; D H Park; T H Joh; V M Pickel
Journal:  Brain Res       Date:  1984-06-08       Impact factor: 3.252

5.  Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum.

Authors:  J B Daunais; D C Roberts; J F McGinty
Journal:  Neuroreport       Date:  1993-05       Impact factor: 1.837

6.  Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes.

Authors:  J K Wang
Journal:  J Neurochem       Date:  1991-09       Impact factor: 5.372

7.  Detection of fos protein during osteogenesis by monoclonal antibodies.

Authors:  P De Togni; H Niman; V Raymond; P Sawchenko; I M Verma
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

8.  Identification of an AP-1 transcription factor binding site within the human cholecystokinin (CCK) promoter.

Authors:  H J Monstein
Journal:  Neuroreport       Date:  1993-02       Impact factor: 1.837

9.  Diazepam dependence prevented by glutamate antagonists.

Authors:  K G Steppuhn; L Turski
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

Review 10.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

View more
  30 in total

Review 1.  Recent advances in the biology of addiction.

Authors:  S E Hemby
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

Review 2.  Drugs of abuse and immediate-early genes in the forebrain.

Authors:  R E Harlan; M M Garcia
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

Review 3.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

4.  Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals.

Authors:  E J Curran; H Akil; S J Watson
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

5.  Acute morphine affects the rat circadian clock via rhythms of phosphorylated ERK1/2 and GSK3β kinases and Per1 expression in the rat suprachiasmatic nucleus.

Authors:  Dominika Pačesová; Barbora Volfová; Kateřina Červená; Lucie Hejnová; Jiří Novotný; Zdeňka Bendová
Journal:  Br J Pharmacol       Date:  2015-05-11       Impact factor: 8.739

6.  Chronic cocaine administration switches corticotropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum.

Authors:  Jie Liu; Baojian Yu; Luis Orozco-Cabal; Dimitri E Grigoriadis; Jean Rivier; Wylie W Vale; Patricia Shinnick-Gallagher; Joel P Gallagher
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

7.  Parallel modulation of receptor for activated C kinase 1 and protein kinase C-alpha and beta isoforms in brains of morphine-treated rats.

Authors:  P V Escribá; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

8.  Gabapentin completely attenuated the acute morphine induced c-Fos expression in the rat striatum.

Authors:  Jamil Ahsan Kazi; Chen Fun Gee
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

9.  Visualizing acute pain-morphine interaction in descending monoamine nuclei with Fos.

Authors:  Dusica Bajic; Kathryn G Commons
Journal:  Brain Res       Date:  2009-10-13       Impact factor: 3.252

10.  Effects of dopamine and NMDA receptors on cocaine-induced Fos expression in the striatum of Fischer rats.

Authors:  Wei-Lun Sun; Luyi Zhou; Ruhal Hazim; Vanya Quinones-Jenab; Shirzad Jenab
Journal:  Brain Res       Date:  2008-09-16       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.